跳至主要内容
临床试验/NL-OMON35325
NL-OMON35325已完成不适用

Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thrombo-embolic infra-inguinal disease. - DUET study

Sint Antonius Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with recently (between 1 and 7 weeks) thrombosed femoro-popliteal or femoro-crural native arteries with ischemic complaints.
  • 2. Patients with recently (between 1 and 7 weeks) thrombosed femoro-popliteal or femoro-crural venous or prosthetic bypass grafts with ischemic complaints.
  • 3. Limb ischemia class I and IIa according to the Rutherford classification for acute ischemia.
  • 4. Patients >18 years and < 85 years old.
  • 5. Patients understand the nature of the procedure and provide written informed consent, prior to enrolment in the study

排除标准

  • 1. Patients with isolated common femoral artery thrombosis including the origin of the superficial femoral artery and profunda femoral artery.
  • 2. Patients with localized (<5 cm) emboli / occlusions in the native femoropopliteal arteries
  • 3. Patients with clinical complaints of lower limb ischemia due to thrombosis of the native femoro-crural arteries or femoro-popliteal and femoro-crural bypass grafts <1 week and >7 weeks.
  • 4. Patients with acute lower limb ischemia class IIb and III according to the Rutherford classification (see below).
  • 5. Patients for whom antiplatelet therapy, anticoagulants or thrombolytic drugs are contraindicated
  • 6. Recent (< 6 weeks) ischemic stroke or cerebral bleeding
  • 7. Patients with recent (<6 weeks) surgery
  • 8. Severe hypertension (diastolic blood pressure >110 mmHg, systolic blood pressure >200 mmHg)
  • 9. Current malignancy
  • 10. Patients with a history of prior life-threatening contrast medium reaction
  • 11. Patients with uncorrected bleeding disorders (GI ulcera, mennorrhagia, liver failure)
  • 12. Female patients with child bearing potential not taking adequate contraceptives or currently breastfeeding.
  • 13. Pregnancy
  • 14. Any patient considered to be hemodynamically unstable at onset of procedure
  • 15. Patients refusing treatment.
  • 16. Patients currently participating in another investigational drug or device study that have not completed the entire follow up period.
  • 17. Patients < 18 years or >85 years old.
  • 18. Severe co-morbid condition with life expectancy < 1 month
  • 19. Contra-indication for MRI

研究者

相似试验